Somebody should look at all of these at once

The review that is already paid for

A Part D sponsor must have a medication therapy management program designed to make sure the drugs prescribed to targeted members are used appropriately, and to reduce the risk of adverse events including drug interactions. It can be delivered by a pharmacist or another qualified provider.

Opt-out enrollment is the reason this is worth a phone call rather than an application. A parent who qualifies is already in the program; the letter offering the review is the one that went in the bin with the plan's other post.

Whether your parent qualifies

Who the plan must target is set by regulation, and two of the three tests are ceilings on how demanding the plan may be rather than hurdles for the patient. A plan may require multiple chronic diseases, but no more than three. It may require multiple Part D drugs, but no more than eight. And it may require that the member is likely to incur annual Part D drug costs at or above a threshold CMS sets each year.

Since 2025, when identifying who has multiple chronic diseases, a plan must include Alzheimer's disease in the list of qualifying conditions, along with bone disease and arthritis including osteoporosis, osteoarthritis and rheumatoid arthritis, chronic congestive heart failure, diabetes and dyslipidemia. It may include more. There is a second route in as well: members who are at-risk beneficiaries under the plan's drug management program.

If the plan says your parent is not enrolled, ask which of the three limbs it says is not met. A plan cannot require four chronic conditions or nine drugs, and knowing that turns a closed answer into a checkable one.

What to bring, and what to ask

The review is a consultation rather than a form, and its value depends almost entirely on what is in front of the pharmacist. The traditional instruction — bring everything in a bag — is still the right one, and it means everything.

• Every prescription, including ones from a hospital stay that were never stopped.
• Everything bought over the counter, including painkillers, antacids, sleep aids and anything for a cold.
• Vitamins, supplements and herbal preparations, which interact and are almost never mentioned.
• Eye drops, creams, patches and inhalers, which people do not think of as medicines.
• The names of every prescriber, and every pharmacy used — the whole problem is usually that no one of them can see the others.

Do not stop anything on the strength of a review alone. The pharmacist recommends; the prescriber decides. Ask for the written summary and take it to the prescribing doctor.

Getting rid of what is left over

A cupboard of discontinued medicines is a safety problem in a house where somebody is confused, and a theft risk in a house where caregivers come and go. The plan is required to provide information at least annually about safe disposal of controlled substances, drug take-back programs and in-home disposal — so the plan itself is one place to ask.

• Authorized collection sites at pharmacies and law enforcement premises take back controlled substances year-round; the Drug Enforcement Administration publishes a search for them.
• A small, specific list of medicines is meant to be flushed rather than binned because of how dangerous a single dose is to somebody else — it is a named list rather than a general rule, and the pharmacist filling the prescription can say whether a particular one is on it.
• Keep a photograph of the label before disposing of anything that is being stopped, so the record survives the bottle.

Where a parent's confusion is part of the picture, clearing out what is no longer prescribed is one of the few interventions that is both immediate and free.